About this FactMed analysis covering adverse side effect reports of AEB071 patients who developed SURGERY.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 1 individuals taking AEB071 reported SURGERY to the FDA. A total of 37 AEB071 drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between AEB071 and SURGERY. In doing so, we compare AEB071 with other drugs that cause SURGERY, to help you evaluate whether or not AEB071 causes SURGERY. Likewise, this page shows the most highly-reported side effects of AEB071, so you can see if SURGERY ranks among AEB071's most well-known side effects.
Summary Statistics
Reports of AEB071 causing SURGERY: 1
Reports of any side effect of AEB071 : 37
Percentage of AEB071 patients where SURGERY is a reported side effect: 2.7027%

FDA reports of any drug causing SURGERY : 12034
Average percentage for all medicated patients where SURGERY is reported as a complication: 0.0754%

Physician opinion on AEB071 as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing AEB071:
RENAL TRANSPLANT ( 34 patients )
( 0 patients )
Drugs with high FDA adverse event association with SURGERY:

FORTEO (1076 patients)
ZOMETA (972 patients)
REMICADE (853 patients)
DIGOXIN (803 patients)
ASPIRIN (740 patients)
AVONEX (623 patients)
LIPITOR (532 patients)
AREDIA (503 patients)
NEXIUM (493 patients)
LASIX (473 patients)
TYSABRI (447 patients)
ENBREL (444 patients)
LYRICA (439 patients)
HUMIRA (424 patients)
GLEEVEC (403 patients)
CELEBREX (400 patients)
SEROQUEL (394 patients)
CHANTIX (380 patients)
COUMADIN (365 patients)
NEURONTIN (359 patients)
LISINOPRIL (352 patients)
DIOVAN (345 patients)
FOSAMAX (339 patients)
PREDNISONE (337 patients)
FUROSEMIDE (322 patients)
OXYCONTIN (308 patients)
CYMBALTA (295 patients)
CALCIUM (295 patients)
VIOXX (284 patients)
PRILOSEC (282 patients)
XANAX (277 patients)
PROTONIX (277 patients)
PLAVIX (276 patients)
POTASSIUM CHLORIDE (269 patients)
SYNTHROID (263 patients)
AMBIEN (253 patients)
DURAGESIC-100 (246 patients)
ZOLOFT (245 patients)
ATENOLOL (235 patients)
VITAMIN D (233 patients)
CLOZARIL (232 patients)
GABAPENTIN (227 patients)
NEORAL (223 patients)
OMEPRAZOLE (223 patients)
TOPROL-XL (222 patients)
METHOTREXATE (221 patients)
ALBUTEROL (219 patients)
ZOCOR (209 patients)
ARIMIDEX (202 patients)
EXJADE (202 patients)
COREG (201 patients)
PREDNISOLONE (201 patients)
FOLIC ACID (198 patients)
SIMVASTATIN (195 patients)
LORTAB (193 patients)
CRESTOR (192 patients)
NORVASC (190 patients)
PERCOCET (189 patients)
LANTUS (188 patients)
WARFARIN SODIUM (188 patients)
PREMARIN (179 patients)
PREVACID (179 patients)
LEVAQUIN (174 patients)
HYDROCODONE (174 patients)
ATIVAN (171 patients)
HUMALOG (169 patients)
DIOVAN HCT (169 patients)
LORAZEPAM (169 patients)
DECADRON (168 patients)
LEXAPRO (166 patients)
NITROGLYCERIN (160 patients)
LEVOTHYROXINE SODIUM (158 patients)
DEXAMETHASONE (154 patients)
METFORMIN HCL (152 patients)
SANDOSTATIN LAR (151 patients)
MORPHINE (151 patients)
SPIRONOLACTONE (151 patients)
ALPRAZOLAM (147 patients)
VICODIN (145 patients)
PAXIL (144 patients)
FEMARA (143 patients)
ACLASTA (143 patients)
ADVAIR DISKUS 100/50 (140 patients)
TAXOTERE (140 patients)
OXYCODONE HCL (138 patients)
HYDROCHLOROTHIAZIDE (137 patients)
SPIRIVA (134 patients)
MULTI-VITAMINS (131 patients)
INSULIN (129 patients)
VOLTAREN (129 patients)
CHEMOTHERAPEUTICS NOS (128 patients)
PROZAC (125 patients)
POTASSIUM (125 patients)
CYCLOSPORINE (124 patients)
METOPROLOL TARTRATE (124 patients)
BYETTA (123 patients)
ZOLEDRONIC ACID (123 patients)
TRACLEER (123 patients)
TAMOXIFEN CITRATE (122 patients)
ZELNORM (120 patients)
IBUPROFEN (116 patients)
ACETAMINOPHEN (115 patients)
PREDNISONE TAB (113 patients)
AVANDIA (112 patients)
CEPHALEXIN (110 patients)
EFFEXOR (110 patients)
KLOR-CON (109 patients)
SANDIMMUNE (108 patients)
AMOXICILLIN (107 patients)
BEXTRA (107 patients)
ALDACTONE (106 patients)
WELLBUTRIN (105 patients)
LOVENOX (104 patients)
METOPROLOL (104 patients)
DIAZEPAM (104 patients)
CLONIDINE (104 patients)
MORPHINE SULFATE (103 patients)
ALLOPURINOL (103 patients)
HYDROCODONE BITARTRATE (102 patients)
LETAIRIS (102 patients)
EXELON (102 patients)
CLONAZEPAM (101 patients)
KLONOPIN (101 patients)
TEGRETOL (101 patients)
MULTI-VITAMIN (100 patients)
DIFLUCAN (99 patients)
ATROVENT (99 patients)
COLACE (99 patients)
LOPRESSOR (98 patients)
FLEXERIL (98 patients)
CARBOPLATIN (97 patients)
VIAGRA (96 patients)
XELODA (96 patients)
VALIUM (96 patients)
MYCOPHENOLATE MOFETIL (95 patients)
THALIDOMIDE (95 patients)
CARDIZEM (93 patients)
OXYCODONE (93 patients)
ARANESP (92 patients)
CELEXA (92 patients)
TRAZODONE HCL (91 patients)
EVISTA (90 patients)
VITAMIN B-12 (89 patients)
SKELAXIN (88 patients)
TRAMADOL HCL (88 patients)
STEROIDS NOS (88 patients)
ZYPREXA (88 patients)
ZETIA (88 patients)
TEMAZEPAM (86 patients)
FLOMAX (86 patients)
ZANTAC (86 patients)
GLIPIZIDE (85 patients)
COMPAZINE (85 patients)
DILAUDID (85 patients)
ALTACE (85 patients)
CARVEDILOL (84 patients)
SINGULAIR (84 patients)
ZYRTEC (83 patients)
AMLODIPINE (83 patients)
MS CONTIN (82 patients)
TAXOL (82 patients)
ENALAPRIL MALEATE (80 patients)
PROMETHAZINE (80 patients)
XALATAN (80 patients)
CIPRO (79 patients)
TYLENOL (78 patients)
ACTOS (78 patients)
FLAGYL (78 patients)
HEPARIN (77 patients)
NEXAVAR (76 patients)
SOMA (76 patients)
FENTANYL (76 patients)
ZOFRAN (75 patients)
CALCIUM CARBONATE (74 patients)
REVLIMID (74 patients)
ALENDRONATE SODIUM (74 patients)
CIALIS (73 patients)
EFFEXOR XR (73 patients)
TRILEPTAL (73 patients)
AZITHROMYCIN (72 patients)
BACLOFEN (72 patients)
CIPROFLOXACIN (72 patients)
HERCEPTIN (72 patients)
REGLAN (71 patients)
IRON (71 patients)
FERROUS SULFATE TAB (71 patients)
TYLENOL (CAPLET) (71 patients)
CELLCEPT (71 patients)
FLUCONAZOLE (70 patients)
ALL OTHER THERAPEUTIC PRODUCTS (70 patients)
TOPAMAX (69 patients)
GEMZAR (69 patients)
VANCOMYCIN (69 patients)
RISPERDAL (69 patients)
LEVOXYL (68 patients)
KEFLEX (68 patients)
NYSTATIN (67 patients)
AROMASIN (67 patients)
SIMULECT (67 patients)
PAMIDRONATE DISODIUM (66 patients)
K-DUR (66 patients)
AMIODARONE HCL (66 patients)
ASCORBIC ACID (66 patients)
VERAPAMIL (66 patients)
VITAMIN E (65 patients)
RADIATION THERAPY (65 patients)
GLUCOPHAGE (65 patients)
FISH OIL (64 patients)
CYTOXAN (64 patients)
BETASERON (64 patients)
Most common side effects for patients taking AEB071:
VOMITING (6 patients)
NEPHROTIC SYNDROME (5 patients)
PROTEINURIA (5 patients)
ANOREXIA (4 patients)
ASTHENIA (4 patients)
DIZZINESS (4 patients)
FUNGAL OESOPHAGITIS (4 patients)
GASTRIC ULCER HAEMORRHAGE (4 patients)
GASTRITIS (4 patients)
KIDNEY TRANSPLANT REJECTION (4 patients)
NAUSEA (4 patients)
REFLUX OESOPHAGITIS (4 patients)
DIARRHOEA (3 patients)
DRUG INEFFECTIVE (3 patients)
ELECTROCARDIOGRAM QT PROLONGED (3 patients)
FEELING ABNORMAL (3 patients)
GLOMERULONEPHRITIS (3 patients)
HAEMOGLOBIN DECREASED (3 patients)
INCISION SITE PAIN (3 patients)
INSOMNIA (3 patients)
POST PROCEDURAL HAEMATOMA (3 patients)
PULMONARY EMBOLISM (3 patients)
ANURIA (2 patients)
BLOOD ALBUMIN DECREASED (2 patients)
CONSTIPATION (2 patients)
COUGH (2 patients)
DRUG INTERACTION (2 patients)
EAR PAIN (2 patients)
FATIGUE (2 patients)
FEBRILE NEUTROPENIA (2 patients)
GASTROENTERITIS (2 patients)
GASTROINTESTINAL INFECTION (2 patients)
HIATUS HERNIA (2 patients)
HYPOTENSION (2 patients)
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED (2 patients)
INFECTION (2 patients)
NASAL CONGESTION (2 patients)
PHARYNGOLARYNGEAL PAIN (2 patients)
PNEUMOCOCCAL SEPSIS (2 patients)
PNEUMONIA (2 patients)
POST PROCEDURAL HAEMORRHAGE (2 patients)
PSEUDOMONAS INFECTION (2 patients)
PYREXIA (2 patients)
RENAL IMPAIRMENT (2 patients)
UPPER-AIRWAY COUGH SYNDROME (2 patients)
URINARY TRACT INFECTION (2 patients)
URINOMA (2 patients)
ABDOMINAL PAIN (1 patients)
AGEUSIA (1 patients)
ANAEMIA (1 patients)
BACTERIAL INFECTION (1 patients)
BLADDER CATHETER REMOVAL (1 patients)
BLADDER CATHETERISATION (1 patients)
BLADDER OPERATION (1 patients)
BLOOD POTASSIUM DECREASED (1 patients)
BLOOD POTASSIUM INCREASED (1 patients)
COAGULOPATHY (1 patients)
CYSTOSTOMY (1 patients)
DEATH (1 patients)
DECREASED APPETITE (1 patients)
DEHYDRATION (1 patients)
DYSLIPIDAEMIA (1 patients)
DYSPEPSIA (1 patients)
DYSPNOEA (1 patients)
ELECTROCARDIOGRAM ABNORMAL (1 patients)
FALL (1 patients)
GASTROINTESTINAL HAEMORRHAGE (1 patients)
HAEMORRHOIDS (1 patients)
HEPATIC FUNCTION ABNORMAL (1 patients)
HYPERCALCAEMIA (1 patients)
HYPERGLYCAEMIA (1 patients)
HYPOXIA (1 patients)
INFLAMMATION (1 patients)
INTERNATIONAL NORMALISED RATIO DECREASED (1 patients)
KIDNEY FIBROSIS (1 patients)
LYMPHATIC FISTULA (1 patients)
LYMPHOCELE (1 patients)
OCCULT BLOOD POSITIVE (1 patients)
OEDEMA (1 patients)
OEDEMA PERIPHERAL (1 patients)
PROTEIN TOTAL DECREASED (1 patients)
PROTHROMBIN TIME PROLONGED (1 patients)
PYELONEPHRITIS (1 patients)
RECTAL HAEMORRHAGE (1 patients)
RENAL ATROPHY (1 patients)
RENAL FAILURE ACUTE (1 patients)
RENAL TUBULAR NECROSIS (1 patients)
SCROTAL OEDEMA (1 patients)
SEPSIS (1 patients)
SEPTIC SHOCK (1 patients)
SHOCK HAEMORRHAGIC (1 patients)
SKIN LESION (1 patients)
SURGERY (1 patients)
TACHYCARDIA (1 patients)
TOXICITY TO VARIOUS AGENTS (1 patients)
URETHRAL DILATATION (1 patients)
URETHRAL OPERATION (1 patients)
URETHRAL STENOSIS (1 patients)
URINARY TRACT INFECTION PSEUDOMONAL (1 patients)
UROSTOMY (1 patients)
VESICOURETERAL REFLUX SURGERY (1 patients)
WEIGHT DECREASED (1 patients)
WEIGHT INCREASED (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for AEB071


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about SURGERY and AEB071, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking AEB071, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in AEB071. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for AEB071 experts. If you are a healthcare provider experienced in prescribing AEB071, please register here.
giCould not connect: